« Back
Home /
CDK9-IN-8

CDK9-IN-8

Item no.	HY-102039-1mg
Manufacturer	MedChem Express
CASRN	2105956-51-0
Amount	1 mg
Quantity options	100 mg 10 mg 1 mg 25 mg 50 mg 5 mg
Specific against	other
Purity	99.65
Citations	[1]Li Y, et al. Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3231-3237.
Smiles	FC1=CC=C(NC(C2(CC2)C(NC3=CC=C(NC4=NC=C5C(N(C6CCCC6)C(C(N(C)C)=O)=C5)=N4)C=C3)=O)=O)C=C1
Available
Product Description	CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC50 of 12 nM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	569.63
Clinical Information	No Development Reported
Manufacturers Research Area	Cancer
Solubility	DMSO : 5.2 mg/mL (ultrasonic; warming; heat to 80°C)\|H2O : 1 mg/mL (ultrasonic; warming; heat to 80°C)
Target	CDK
Manufacturers Target	CDK
Isoform	CDK9
Manufacturers Pathway	Cell Cycle/DNA Damage
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Request delivery time